1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.

Neurocrine Biosciences, Inc.

XNAS: NBIX

Falling Comet
Download real time

96.16 1.27 (1.34%)

New 52W Low in past week

1.7M XNAS Volume

XNAS 15 Apr, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Share
15S
10W
1O
3T
9,513.9

Market Cap

High in industry
27.9

PE TTM

High in industry
0.8

PEG TTM

PEG TTM is less than 1
3.7

Price to Book

Below industry Median
0.5

Beta 1Year

Very Low volatility
Analyst Upgrade
Needham upgrades Neurocrine Bio to 'Buy'; cites positive physician survey of its drug, 'Crenessity' See details